Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.
June 18, 2020

Four-Month Pilot Aims to Address Illegal Online Opioid Sales

Partner Libby Baney and director Matthew Rubin co-authored an article for The National Association of Boards of Pharmacy titled “Four-Month Pilot Aims to Address Illegal Online Opioid Sales,” regarding the formation of a 120-day pilot program targeting the illegal advertisement and sale of prescription opioids and illicit narcotics online.

Food and Drug Administration (FDA) and Department of Commerce’s National Telecommunications and Information Administration (NTIA) formally announced the pilot on June 8. The pilot includes representatives from FDA, NTIA, and three United States-based domain name registries.

Baney and Rubin identify several voluntary pathways registries maintain to mitigate harm to consumers and the proliferation of dangerous content online, such as locking the domain to avoid transfer of the content to an alternate URL or platform, deleting the domain from the registry, or placing a hold on the domain until a further review is completed.

Full Article

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.